Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $11,426 - $12,749
-111 Reduced 3.53%
3,033 $322,000
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $19,674 - $25,224
-225 Reduced 6.68%
3,144 $348,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $156,877 - $177,828
-1,879 Reduced 35.8%
3,369 $307,000
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $136,949 - $153,511
-1,863 Reduced 26.2%
5,248 $431,000
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $1,011 - $1,267
-14 Reduced 0.2%
7,111 $545,000
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $66,447 - $73,075
-927 Reduced 11.51%
7,125 $535,000
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $55,474 - $61,360
-789 Reduced 8.92%
8,052 $626,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $331,649 - $368,062
4,621 Added 109.5%
8,841 $723,000
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $260,979 - $361,730
-4,119 Reduced 49.39%
4,220 $325,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $28,627 - $32,302
369 Added 4.63%
8,339 $758,000
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $355,674 - $387,697
-4,675 Reduced 36.97%
7,970 $671,000
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $62,856 - $73,431
-900 Reduced 6.64%
12,645 $1.08 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $26,649 - $30,394
383 Added 2.91%
13,545 $1.13 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $115,996 - $134,612
-1,778 Reduced 11.9%
13,162 $1.01 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $50,190 - $59,020
870 Added 6.18%
14,940 $1.06 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $16,265 - $19,110
-320 Reduced 2.22%
14,070 $854,000
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $129,948 - $151,036
-2,550 Reduced 15.05%
14,390 $784,000
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $874,442 - $1.04 Million
16,940
16,940 $953,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Unio Capital LLC Portfolio

Follow Unio Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unio Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unio Capital LLC with notifications on news.